Pharmacology of BS 100-141, a centrally acting antihypertensive drug.
D000316:Adrenergic alpha-Agonists / Q000494:pharmacology; D000818:Animals; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D001158:Arteries / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D001923:Brain Chemistry / Q000187:drug effects; D002415:Cats; D003000:Clonidine / Q000494:pharmacology; D003900:Desoxycorticosterone / Q000494:pharmacology; D004285:Dogs; D004569:Electroencephalography; D006146:Guanidines / Q000494:pharmacology*; D007275:Injections, Intravenous; D007276:Injections, Intraventricular; D007668:Kidney / Q000502:physiology; D009119:Muscle Contraction / Q000187:drug effects; D010648:Phenylacetates / Q000494:pharmacology*; D051381:Rats; D012890:Sleep / Q000187:drug effects; D013997:Time Factors; D014680:Veins / Q000187:drug effects
D000316:Adrenergic alpha-Agonists; D000959:Antihypertensive Agents; D006146:Guanidines; D010648:Phenylacetates; D003900:Desoxycorticosterone; D003000:Clonidine